![Jean-Marc Hagai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jean-Marc Hagai
Corporate Officer/Principal at
POLYPID LTD.
Profile
Jean-Marc Hagai currently works at PolyPid Ltd., as Chief Commercial Officer.
Dr. Hagai also formerly worked at Teva Pharmaceutical Industries Ltd., as Global Head-Womens Health Portfolio from 2013 to 2014 and Aurum Ventures MKI Ltd., as Vice President-Business Development from 2015 to 2017.
Jean-Marc Hagai active positions
| Companies | Position | Start |
|---|---|---|
| POLYPID LTD. | Corporate Officer/Principal | - |
Former positions of Jean-Marc Hagai
| Companies | Position | End |
|---|---|---|
Aurum Ventures MKI Ltd.
 Aurum Ventures MKI Ltd. Investment ManagersFinance Aurum Ventures invests in companies located in Israel. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provides financing for early stage capital requirements. | Corporate Officer/Principal | 2016-12-31 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 2014-03-31 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
51
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Aurum Ventures MKI Ltd.
Aurum Ventures MKI Ltd. Investment ManagersFinance Aurum Ventures invests in companies located in Israel. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provides financing for early stage capital requirements. | Finance |
PolyPid Ltd.
 PolyPid Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage specialty pharmaceutical company that is engaged in developing of product candidates based on polymer-lipid encapsulation matrix technology | Health Technology |
- Stock Market
- Insiders
- Jean-Marc Hagai
